본문 바로가기

Greetings-BPRC will be a pillar for sustaining Korean biotechnology as a national core industry BPRC-Biotech Policy Research Center-will be a pillar for sustaining Korean biotechnology as a national core industry

Global BT News

Lilly says antibody drug cuts COVID-19 ri...  
A trial of Eli Lilly and Co’s antibody drug shows it can cut the risk of COVID-19 by 80% for nursing home residents, the company said on Thursday, although the need for such disease prevention tools has dwindled as vacc...

more >

Publications